Zafer Buyukterzi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zafer Buyukterzi has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Sukru Karaarslan
Department of Cardiology, Konya Training and Research Hospital, University of Health Sciences, Meram, 42090, Konya, Turkey
6 shared publicationsMehmet Sertac Alpaydin
Department of Cardiology, Konya Training and Research Hospital, University of Health Sciences, Meram, 42090, Konya, Turkey
5 shared publicationsAsuman Guzelant
Department of Microbiology, Konya Training and Research Hospital, University of Health Sciences, Meram, Konya, Turkey
4 shared publications- Hüseyin Tezcan
Department of Cardiology, Konya Selcuk University Medical Faculty Hospital, Konya, Turkey
4 shared publications Mehmet Mustu
Department of Cardiology, Konya Training and Research Hospital, University of Health Sciences, Meram, 42090, Konya, Turkey
3 shared publicationsSertac Alpaydin
Department of Cardiology, Konya Training and Research Hospital, University of Health Sciences, Meram, Konya, Turkey
3 shared publications
Latest Publications
- Open Access
- 24 September 2025
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 27 (9) , e70159
Effect of Ramadan Fasting on Blood Pressure and Kidney Functions in Newly Diagnosed Hypertensive Patients: A Study in Konya, Turkey
- 24 September 2025
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 27 (9) , e70159
Open AccessEffect of Ramadan Fasting on Blood Pressure and Kidney Functions in Newly Diagnosed Hypertensive Patients: A Study in Konya, Turkey
- Open Access
- 18 August 2025
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 27 (8) , e70125
Effect of Ramadan Fasting on Blood Pressure and Kidney Functions in Newly Diagnosed Hypertensive Patients: A Study in Konya, Turkey
Ramadan fasting involves abstaining from food and drink from dawn to sunset, yet its impact on blood pressure (BP) and kidney function in newly diagnosed hypertensive patients remains unclear. This retrospective study examined 200 newly diagnosed hypertensive patients from Konya, Turkey, during Ramadan 2023. Half of the patients (n = 100) observed daily fasting throughout Ramadan, while the other half (n = 100) did not. All patients received a diuretic‐containing regimen consisting of an angiotensin‐converting enzyme inhibitor or angiotensin receptor blocker combined with hydrochlorothiazide. Baseline clinical and laboratory data, including serum creatinine and estimated glomerular filtration rate (eGFR), were compared with those obtained at a one‐month follow‐up (end of Ramadan). Both fasting and non‐fasting groups exhibited significant reductions in systolic and diastolic BP from baseline to the first month, with no statistically significant difference in final BP between the two groups. Kidney function, as indicated by creatinine levels and eGFR, remained stable in both groups, suggesting that Ramadan fasting did not adversely affect renal parameters. Modest improvements in lipid profiles were also observed in both cohorts. These findings indicate that, among newly diagnosed hypertensive patients on diuretic‐containing therapy, Ramadan fasting may be safe if accompanied by individualized clinical advice. However, larger and more prolonged studies are warranted to validate these results and explore potential variations in other hypertensive populations.
- 18 August 2025
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 27 (8) , e70125
Open AccessEffect of Ramadan Fasting on Blood Pressure and Kidney Functions in Newly Diagnosed Hypertensive Patients: A Study in Konya, Turkey
Ramadan fasting involves abstaining from food and drink from dawn to sunset, yet its impact on blood pressure (BP) and kidney function in newly diagnosed hypertensive patients remains unclear. This retrospective study examined 200 newly diagnosed hypertensive patients from Konya, Turkey, during Ramadan 2023. Half of the patients (n = 100) observed daily fasting throughout Ramadan, while the other half (n = 100) did not. All patients received a diuretic‐containing regimen consisting of an angiotensin‐converting enzyme inhibitor or angiotensin receptor blocker combined with hydrochlorothiazide. Baseline clinical and laboratory data, including serum creatinine and estimated glomerular filtration rate (eGFR), were compared with those obtained at a one‐month follow‐up (end of Ramadan). Both fasting and non‐fasting groups exhibited significant reductions in systolic and diastolic BP from baseline to the first month, with no statistically significant difference in final BP between the two groups. Kidney function, as indicated by creatinine levels and eGFR, remained stable in both groups, suggesting that Ramadan fasting did not adversely affect renal parameters. Modest improvements in lipid profiles were also observed in both cohorts. These findings indicate that, among newly diagnosed hypertensive patients on diuretic‐containing therapy, Ramadan fasting may be safe if accompanied by individualized clinical advice. However, larger and more prolonged studies are warranted to validate these results and explore potential variations in other hypertensive populations.
- Open Access
- 18 January 2024
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (2) , 283-288
Reticulated platelets and coronary slow flow: a study in stable coronary artery disease
Objectives: The coronary slow flow (CSF) phenomenon remains a clinical enigma, characterized by delayed opacification of coronary vessels despite angiographically normal or nearly normal arteries. This cross-sectional study explores the potential relationship between reticulated platelets (RPs) and CSF in stable coronary artery disease patients. Methods: A total of 200 participants, meeting specific inclusion and exclusion criteria, underwent coronary angiography. Reticulated platelet levels were measured using Sysmex series hematology analyzers. Demographic data, laboratory parameters, and coronary flow velocities were assessed. Results: The study comprised 100 individuals with CSF and 100 with normal coronary anatomy. The CSF group exhibited higher rates of diabetes (35 vs. 22 %, p=0.017) and smoking (62 vs. 45 %, p=0.021). Reticulated platelet rates were elevated in the CSF group. However, statistical significance was not reached (p=0.105). Conclusions: This study provides insights into the interplay between reticulated platelets and the CSF phenomenon in stable coronary artery disease. Although reticulated platelet levels did not emerge as a major predictor for CSF in this stable phase, the findings contribute to ongoing efforts to understand the multifaceted mechanisms underlying CSF.
- 18 January 2024
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (2) , 283-288
Open AccessReticulated platelets and coronary slow flow: a study in stable coronary artery disease
Objectives: The coronary slow flow (CSF) phenomenon remains a clinical enigma, characterized by delayed opacification of coronary vessels despite angiographically normal or nearly normal arteries. This cross-sectional study explores the potential relationship between reticulated platelets (RPs) and CSF in stable coronary artery disease patients. Methods: A total of 200 participants, meeting specific inclusion and exclusion criteria, underwent coronary angiography. Reticulated platelet levels were measured using Sysmex series hematology analyzers. Demographic data, laboratory parameters, and coronary flow velocities were assessed. Results: The study comprised 100 individuals with CSF and 100 with normal coronary anatomy. The CSF group exhibited higher rates of diabetes (35 vs. 22 %, p=0.017) and smoking (62 vs. 45 %, p=0.021). Reticulated platelet rates were elevated in the CSF group. However, statistical significance was not reached (p=0.105). Conclusions: This study provides insights into the interplay between reticulated platelets and the CSF phenomenon in stable coronary artery disease. Although reticulated platelet levels did not emerge as a major predictor for CSF in this stable phase, the findings contribute to ongoing efforts to understand the multifaceted mechanisms underlying CSF.
- 16 January 2024
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 6 (1) , 1-6
Comparative Patient Satisfaction in Coronary Percutaneous Interventions: A Dual Experience with Transradial and Transfemoral Access
- 16 January 2024
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 6 (1) , 1-6
Comparative Patient Satisfaction in Coronary Percutaneous Interventions: A Dual Experience with Transradial and Transfemoral Access
- 30 June 2022
- Published by Celal Bayar Universitesi Saglık Bilimleri Enstitusu Dergisi in Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
- Vol. 9 (2) , 228-233
Association Between Index of Cardio‐Electrophysiological Balance and Cardiac Remodeling
Objective: Pathophysiological changes in response to myocardial infarction (MI) result in cardiac remodeling. Left untreated this pathologic process contributes to impairment of ventricular function and development of malignant ventricular arrhythmias. Recently introduced ECG‐based marker index of cardio‐electrophysiological balance (iCEB) has been shown to be associated with various cardiac conditions. Herein, we aimed to investigate the association between the iCEB and cardiac remodeling in post-MI patients. Materials and Methods: Patients aged ≥18 years presenting with acute MI who underwent successful percutaneous coronary intervention between January 2020 and January 2021 were recruited. Regarding the assessment of cardiac remodeling, left ventricular (LV) mass, LV mass index (LVMI), and relative wall thickness (RWT) were measured before the start of treatment and six months after the procedure along with the QT/QRS ratio (iCEB), and QTC/QRS ratio (iCEBc). Results: According to our study, estimated QT/QRS (iECB) and QTc/QRS (iECBc) ratios were found to be significantly lower at six-month follow-up compared to baseline values (4.73∓0.60 vs 4.62∓0.55 & 4.93∓0.59 vs 4.78∓0.55, p
- 30 June 2022
- Published by Celal Bayar Universitesi Saglık Bilimleri Enstitusu Dergisi in Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
- Vol. 9 (2) , 228-233
Association Between Index of Cardio‐Electrophysiological Balance and Cardiac Remodeling
Objective: Pathophysiological changes in response to myocardial infarction (MI) result in cardiac remodeling. Left untreated this pathologic process contributes to impairment of ventricular function and development of malignant ventricular arrhythmias. Recently introduced ECG‐based marker index of cardio‐electrophysiological balance (iCEB) has been shown to be associated with various cardiac conditions. Herein, we aimed to investigate the association between the iCEB and cardiac remodeling in post-MI patients. Materials and Methods: Patients aged ≥18 years presenting with acute MI who underwent successful percutaneous coronary intervention between January 2020 and January 2021 were recruited. Regarding the assessment of cardiac remodeling, left ventricular (LV) mass, LV mass index (LVMI), and relative wall thickness (RWT) were measured before the start of treatment and six months after the procedure along with the QT/QRS ratio (iCEB), and QTC/QRS ratio (iCEBc). Results: According to our study, estimated QT/QRS (iECB) and QTc/QRS (iECBc) ratios were found to be significantly lower at six-month follow-up compared to baseline values (4.73∓0.60 vs 4.62∓0.55 & 4.93∓0.59 vs 4.78∓0.55, p
- Open Access
- 21 February 2022
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 140 (2) , 182-187
Scanning of paroxysmal atrial fibrillation as an etiological risk factor in patients with acute ischemic stroke: prospective study
BACKGROUND: Prevention of recurrence of stroke depends on recognition of the underlying mechanism of ischemia. OBJECTIVE: To screen patients who were hospitalized with diagnosis of acute ischemic stroke in terms of atrial fibrillation (AF) with repeated Holter electrocardiography recordings. DESIGN AND SETTING: Prospective study conducted at Konya Education and Research Hospital, Turkey. METHODS: Patients with a diagnosis of acute ischemic stroke, without atrial fibrillation on electrocardiog-raphy (ECG), were evaluated. Their age, gender, histories of previous ischemic attack, occurrences of parox-ysmal atrial fibrillation (PAF) and other risks were assessed during the first week after acute ischemic stroke and one month thereafter. ECG recordings were obtained from 130 patients through 24-hour ambulatory Holter. Patients without PAF attack during the first Holter were re-evaluated. RESULTS: PAF was detected through the first Holter in 33 (25.4%) out of 130 acute ischemic stroke pa-tients. A second Holter was planned for 97 patients: 53 (54.6%) of them could not attend due to COVID-19 pandemic; while 44 (45.3%) patients had the second Holter and, among these, 4 (9.1%) had PAF. The only parameter associated with PAF was older age. Four (10.8%) of the 37 patients with PAF had also symptom-atic carotid stenosis. CONCLUSIONS: Detecting the presence of PAF by screening patients with no AF in the ECG through Holter ECG examinations is valuable in terms of changing the course of the treatment. It should be kept in mind that the possibility of accompanying PAF cannot be ruled out in the presence of other factors that pose a risk of stroke.
- 21 February 2022
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 140 (2) , 182-187
Open AccessScanning of paroxysmal atrial fibrillation as an etiological risk factor in patients with acute ischemic stroke: prospective study
BACKGROUND: Prevention of recurrence of stroke depends on recognition of the underlying mechanism of ischemia. OBJECTIVE: To screen patients who were hospitalized with diagnosis of acute ischemic stroke in terms of atrial fibrillation (AF) with repeated Holter electrocardiography recordings. DESIGN AND SETTING: Prospective study conducted at Konya Education and Research Hospital, Turkey. METHODS: Patients with a diagnosis of acute ischemic stroke, without atrial fibrillation on electrocardiog-raphy (ECG), were evaluated. Their age, gender, histories of previous ischemic attack, occurrences of parox-ysmal atrial fibrillation (PAF) and other risks were assessed during the first week after acute ischemic stroke and one month thereafter. ECG recordings were obtained from 130 patients through 24-hour ambulatory Holter. Patients without PAF attack during the first Holter were re-evaluated. RESULTS: PAF was detected through the first Holter in 33 (25.4%) out of 130 acute ischemic stroke pa-tients. A second Holter was planned for 97 patients: 53 (54.6%) of them could not attend due to COVID-19 pandemic; while 44 (45.3%) patients had the second Holter and, among these, 4 (9.1%) had PAF. The only parameter associated with PAF was older age. Four (10.8%) of the 37 patients with PAF had also symptom-atic carotid stenosis. CONCLUSIONS: Detecting the presence of PAF by screening patients with no AF in the ECG through Holter ECG examinations is valuable in terms of changing the course of the treatment. It should be kept in mind that the possibility of accompanying PAF cannot be ruled out in the presence of other factors that pose a risk of stroke.
- 30 November 2020
- Published by Wiley in Seminars in Dialysis
- Vol. 34 (2) , 157-162
The relationship of soluble klotho level with uremic cardiomyopathy and ecocardiographic parameters in hemodialysis patients
There are studies reporting that soluble kltho (sKlotho) deficiency plays a role in cardiovascular disease in addition to traditional risk factors such as diabetes, hypertension, anemia, smoking, and excessive volume burden. Our aim in this study was to investigate the relationship of sKlotho with uremic cardiomyopathy and echocardiographic parameters in patients receiving hemodialysis treatment. According to the median value, the sKlotho value was divided into two groups as ≥1.24 and <1.24 ng/ml. Ventricular wall thicknesses, ejection fractions, left atrium, M mode aorta systole, and diastole diameter measurements were taken. The left ventricular mass (LVM) was calculated using the Devereux formula. There were significant differences between the two groups in terms of age, number of patients with diabetes mellitus, comorbidity, dialysis time, sKlotho, phosphorus, parathormone, and albumin parameters. No significant difference was found between the two groups that were separated according to the median sKlotho value, when the echocardiographic parameters of interventricular septum thickness, left ventricular posterior wall thickness, left atrial diameter, left ventricular ejection fraction, and LVM index were compared. In conclusion, sKlotho is not a marker for showing and predicting uremic cardiomyopathy in hemodialysis patients.
- 30 November 2020
- Published by Wiley in Seminars in Dialysis
- Vol. 34 (2) , 157-162
The relationship of soluble klotho level with uremic cardiomyopathy and ecocardiographic parameters in hemodialysis patients
There are studies reporting that soluble kltho (sKlotho) deficiency plays a role in cardiovascular disease in addition to traditional risk factors such as diabetes, hypertension, anemia, smoking, and excessive volume burden. Our aim in this study was to investigate the relationship of sKlotho with uremic cardiomyopathy and echocardiographic parameters in patients receiving hemodialysis treatment. According to the median value, the sKlotho value was divided into two groups as ≥1.24 and <1.24 ng/ml. Ventricular wall thicknesses, ejection fractions, left atrium, M mode aorta systole, and diastole diameter measurements were taken. The left ventricular mass (LVM) was calculated using the Devereux formula. There were significant differences between the two groups in terms of age, number of patients with diabetes mellitus, comorbidity, dialysis time, sKlotho, phosphorus, parathormone, and albumin parameters. No significant difference was found between the two groups that were separated according to the median sKlotho value, when the echocardiographic parameters of interventricular septum thickness, left ventricular posterior wall thickness, left atrial diameter, left ventricular ejection fraction, and LVM index were compared. In conclusion, sKlotho is not a marker for showing and predicting uremic cardiomyopathy in hemodialysis patients.
- 1 August 2020
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 36 (8) , 1559-1565
Periaortic adipose tissue volume is associated with sclerotic changes in the adjacent aortic valve
Aortic sclerosis is associated with increased cardiovascular mortality and morbidity. Numerous studies have shown that visceral adiposity is associated with development of atherosclerosis, especially in the adjacent vascular wall. Considering the similar pathophysiology of aortic sclerosis and atherosclerosis, it can be hypothesized that visceral adipose tissue adjacent to aortic valve may be associated with aortic sclerosis. In this study, we investigated the relationship between periaortic adipose tissue volume and sclerotic changes in the adjacent aortic valve. In this retrospective study, 80 patients with a concurrent MSCT and echocardiography in the last 6 months were enrolled. Echocardiographic examinations were retrospectively evaluated regarding the presence of aortic sclerosis. Periaortic adipose tissue volume was calculated on a computer assisted work station (Leonardo Workstation, Siemens, Erlangen, Germany) by an experienced radiologist. Patient group (61.63 +/- 8.55 years and 50% male) and the control group (61.45 +/- 5.68 years, 50% male) each consisted 40 participants. Patient group had significantly higher BUN (42.50 (15.00-211.00) vs. 34.00 (12.00-107.00) mg/dL, p = 0.003), uric acid (5.40 (3.40-14.70) vs. 4.30 (2.30-6.70) ng/mL, p = 0.005) and LDL-C levels (121.50 (60.00-215.00) vs. 86.50 (49.00-209.00) mg/dL, p = 0.001) when compared to control group. Patient group had also significantly higher periaortic adipose tissue volume (32.45 (11.70-51.23) vs. 16.00 (6.29-32.96) ml, p < 0.001). Multivariate regression analysis revealed that periaortic adipose tissue volume was independently associated with the presence of aortic sclerosis (OR 0.241, 95% CI 0.143-0.946, p = 0.001). In this study, we demonstrated for the first time that periaortic adipose tissue volume was independently associated with the presence of sclerotic changes in the adjacent aortic valve.
- 1 August 2020
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 36 (8) , 1559-1565
Periaortic adipose tissue volume is associated with sclerotic changes in the adjacent aortic valve
Aortic sclerosis is associated with increased cardiovascular mortality and morbidity. Numerous studies have shown that visceral adiposity is associated with development of atherosclerosis, especially in the adjacent vascular wall. Considering the similar pathophysiology of aortic sclerosis and atherosclerosis, it can be hypothesized that visceral adipose tissue adjacent to aortic valve may be associated with aortic sclerosis. In this study, we investigated the relationship between periaortic adipose tissue volume and sclerotic changes in the adjacent aortic valve. In this retrospective study, 80 patients with a concurrent MSCT and echocardiography in the last 6 months were enrolled. Echocardiographic examinations were retrospectively evaluated regarding the presence of aortic sclerosis. Periaortic adipose tissue volume was calculated on a computer assisted work station (Leonardo Workstation, Siemens, Erlangen, Germany) by an experienced radiologist. Patient group (61.63 +/- 8.55 years and 50% male) and the control group (61.45 +/- 5.68 years, 50% male) each consisted 40 participants. Patient group had significantly higher BUN (42.50 (15.00-211.00) vs. 34.00 (12.00-107.00) mg/dL, p = 0.003), uric acid (5.40 (3.40-14.70) vs. 4.30 (2.30-6.70) ng/mL, p = 0.005) and LDL-C levels (121.50 (60.00-215.00) vs. 86.50 (49.00-209.00) mg/dL, p = 0.001) when compared to control group. Patient group had also significantly higher periaortic adipose tissue volume (32.45 (11.70-51.23) vs. 16.00 (6.29-32.96) ml, p < 0.001). Multivariate regression analysis revealed that periaortic adipose tissue volume was independently associated with the presence of aortic sclerosis (OR 0.241, 95% CI 0.143-0.946, p = 0.001). In this study, we demonstrated for the first time that periaortic adipose tissue volume was independently associated with the presence of sclerotic changes in the adjacent aortic valve.
- Open Access
- 10 July 2018
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 27 (4) , 397
Reply
Reply ventricular functions following an episode of pulmonary thromboembolism. However, our data was obtained through reviewing the medical records of the patients, and the relationship between routine echocardiographic measurements and subclinical atherosclerosis was shown. We recommend that further prospective studies should investigate this association using more detailed echocardiographic and inflammatory parameters to determine right ventricular functions. Dear Editor, We appreciate the interest of Yildirim et al. in our paper "Subclinical Atherosclerosis in Patients with Prior Pulmonary Thromboembolism" [1]. We agree with their comments regarding the beneficial use of imaging parameters for the evaluation of right
- 10 July 2018
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 27 (4) , 397
Open AccessReply
Reply ventricular functions following an episode of pulmonary thromboembolism. However, our data was obtained through reviewing the medical records of the patients, and the relationship between routine echocardiographic measurements and subclinical atherosclerosis was shown. We recommend that further prospective studies should investigate this association using more detailed echocardiographic and inflammatory parameters to determine right ventricular functions. Dear Editor, We appreciate the interest of Yildirim et al. in our paper "Subclinical Atherosclerosis in Patients with Prior Pulmonary Thromboembolism" [1]. We agree with their comments regarding the beneficial use of imaging parameters for the evaluation of right
- 1 April 2018
- Published by Elsevier in The American Journal of Cardiology
- Vol. 121 (8) , e22
Mean Neutrophil Volume is Elevated in Patients Suffering from Acute Coronary Syndrome
- 1 April 2018
- Published by Elsevier in The American Journal of Cardiology
- Vol. 121 (8) , e22
Mean Neutrophil Volume is Elevated in Patients Suffering from Acute Coronary Syndrome